Question

Difficulty: MediumDiagnostic Workup and Test Sequencing

A 42-year-old man presents to the outpatient clinic reporting chronic diffuse joint pain, increasing fatigue, and excessive sweating over the past year. He mentions that he recently had to purchase larger shoes and his wedding ring can no longer be worn. His medical history includes newly diagnosed type 2 diabetes mellitus and hypertension. Vital signs show a blood pressure of 145/90 mmHg145/90 \text{ mmHg}, a heart rate of 78/min78\text{/min}, and a BMI of 29 kg/m229 \text{ kg/m}^2. Physical examination reveals coarse facial features, a prominent jaw, macroglossia, and enlarged, doughy hands. Initial laboratory testing reveals an elevated serum insulin-like growth factor 1 (IGF-1) concentration for his age and sex. Which of the following is the most appropriate next step in the diagnostic workup?

  1. Measurement of serum growth hormone concentration following an oral glucose loadAnswer
  2. B
    Magnetic resonance imaging of the brain with emphasis on the sella turcica
  3. C
    Measurement of a random fasting serum growth hormone concentration
  4. D
    Formal automated visual field perimetry testing
  5. E
    Transthoracic echocardiography

Answer

Measurement of serum growth hormone concentration following an oral glucose load
The correct sequence for diagnosing acromegaly is step-wise. Following clinical suspicion, the initial screening test is an insulin-like growth factor 1 (IGF-1) level, which is elevated in this patient. Once an elevated IGF-1 level is identified, the diagnosis must be confirmed biochemically before proceeding to anatomical localization. The definitive confirmatory test is the oral glucose tolerance test (OGTT). In normal physiology, a glucose load suppresses GH secretion; in acromegaly, GH levels fail to suppress and remain elevated (typically ≥1 ng/mL\geq 1 \text{ ng/mL}).

Step-by-Step Solution

1
Recognize the clinical syndrome
The patient's coarse facial features, enlarged extremities, hyperhidrosis, and new-onset diabetes are highly suspicious for acromegaly.
Identifying the clinical pattern directs the initial diagnostic pathway toward evaluating growth hormone excess.
2
Evaluate the preliminary diagnostic test
The patient has an elevated serum IGF-1 concentration.
IGF-1 is the preferred initial screening test for acromegaly because it reflects integrated growth hormone secretion without diurnal variation.
3
Determine the required confirmatory step prior to imaging
Select the oral glucose tolerance test (OGTT) with growth hormone measurement.
Diagnostic guidelines dictate that biochemical confirmation of autonomous growth hormone secretion via failure of suppression during an OGTT must be established before performing an MRI to localize a pituitary tumor.

Key Concept

Diagnostic sequencing for acromegaly requires clinical suspicion followed by an elevated IGF-1 (screening), failure to suppress GH following an oral glucose load (confirmation), and finally MRI of the brain (localization).
Rate this question